Dual-chamber pacing for hypertrophic cardiomyopathy: a randomized, double-blind, crossover trial.
about
Pacing for drug-refractory or drug-intolerant hypertrophic cardiomyopathyDual chamber versus single chamber ventricular pacemakers for sick sinus syndrome and atrioventricular blockHypertrophic cardiomyopathy in childhoodHypertrophic cardiomyopathy: management, risk stratification, and prevention of sudden deathSymptomatic hypertrophic obstructive cardiomyopathy: the role of dual-chamber pacing.Permanent pacing: new indications.2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm AssociCurrent status and future perspectives on alcohol septal ablation for hypertrophic obstructive cardiomyopathy.Percutaneous septal ablation for left mid-ventricular obstructive hypertrophic cardiomyopathy: a case reportClinical and echocardiographic features of hypertrophic cardiomyopathy in the elderly.Hypertrophic cardiomyopathy: diagnosis, risk stratification and treatment.Hypertrophic cardiomyopathy: state-of-the-art review, with focus on the management of outflow obstruction.Effect of alcohol septal ablation in patients with hypertrophic cardiomyopathy on left-ventricular mechanical dyssynchrony as assessed by phase analysis of gated SPECT myocardial perfusion imagingHealth-related quality of life in hypertrophic cardiomyopathy patients with implantable defibrillators.Canadian Cardiovascular Society Consensus Conference guidelines on heart failure--2008 update: best practices for the transition of care of heart failure patients, and the recognition, investigation and treatment of cardiomyopathiesSurgical management of obstructive hypertrophic cardiomyopathy: the gold standard.Treating a Structural Heart Disease Using a Non-structural Approach: Role of Cardiac Pacing in Hypertrophic CardiomyopathyDevice therapy in hypertrophic cardiomyopathy.Possible acute and chronic synergistic effect of dual chamber pacing and disopyramide in obstructive hypertrophic cardiomyopathy: a case report.A novel approach in the use of radiofrequency catheter ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy.Initial experience of a cohort of patients with hypertrophic cardiomyopathy undergoing biventricular pacing.Biventricular / left ventricular pacing in hypertrophic obstructive cardiomyopathy: an overview.Long-term follow-up impact of dual-chamber pacing on patients with hypertrophic obstructive cardiomyopathy.Correlations between physician-perceived functional status, patient-perceived health status, and cardiopulmonary exercise results in hypertrophic cardiomyopathy.Intracardiac echocardiography guidance during percutaneous transluminal septal myocardial ablation in patients with obstructive hypertrophic cardiomyopathy.Cardiac resynchronization therapy in patients with end-stage hypertrophic cardiomyopathy.Pacing for hypertrophic obstructive cardiomyopathy: an update and future directions.Dyssynchronization reduces dynamic obstruction without affecting systolic function in patients with hypertrophic obstructive cardiomyopathy: a pilot study.Dual-chamber pacing in hypertrophic obstructive cardiomyopathy with biventricular outflow tract obstruction and severe drug-refractory symptoms in a 9-year-old girl.Comparison of long-term effect of dual-chamber pacing and alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy.Resynchronization or Dyssynchronization?Successful Treatment with Biventricular Stimulation of a Child with Obstructive Hypertrophic Cardiomyopathy without Dyssynchrony
P2860
Q24197872-8034D3B4-BB6F-48B0-9710-91D536F0C5DAQ24247128-53F5F94C-6908-4B87-8E1B-59C0016E8EABQ24599577-5289F2A7-E6D3-4783-A814-0FC22108BFDAQ30478725-A8717120-328F-4F02-BB23-6233275794EEQ33144509-748DE2C4-B6C6-4B79-B320-CB405680165FQ33146725-E0879660-EB16-43AD-AE01-A54390165534Q33162947-6B0D5BA4-73A7-4798-A249-BF7BF17F72F5Q33163967-096D26AF-9D16-4443-89A7-973FDAAA6AB0Q33239512-01CFA82A-5B2C-4293-BA5F-EC6427F98ADDQ34286730-543A5CF0-3CA1-4525-AFD4-758AC3274B7FQ34460145-AFF4B8DA-44CD-4408-81A4-81556D64EEE9Q35600527-B6B56BD0-FDB8-4A31-AEF6-57FB23168FD5Q35946887-AB70E1F5-D88F-4481-BC71-F98B8A9E86AAQ36800366-E7084CDA-D8D3-400A-8903-D586109EE9C2Q37061992-93944019-DFC2-45AF-BD28-BCAC12BD808AQ37176455-2D3E29BD-1000-44AB-8BDA-0F332BE91361Q37684990-CEBB1323-FF74-46DF-B00F-92832ADDBD7BQ37812384-1C964D43-8DFB-4C63-A6EA-DC79522E9B3CQ39295158-8402F3E8-C3E0-40AD-A8A7-AAB91B73B3BCQ41571656-237274C2-1053-45B6-85B5-BCB2D67F93E6Q42079356-3B09AFF9-2937-4420-98CE-02027EF6D021Q42175381-3E30D8BF-BEE6-48F0-A73E-2A06BA566C90Q43926357-1312D387-FAE3-4D97-B00B-A0757452B1CDQ45180177-B5BB1B1B-0319-4B55-B804-8E5C88A05A66Q46769354-87B07657-6FEC-450F-ABF4-9C8310B39EA6Q47190076-AA53ABD4-368E-4D48-A45A-B079F46DDA2BQ47857686-9D1EAD68-E909-4752-B69C-B3F47976EEDEQ48616994-F16DC4A8-B1A8-43AD-96EC-FF28B2D01942Q51790734-A269C46F-C3F7-4393-BBFA-597DFC0652A6Q54471588-5FA6F390-F7EB-47E6-A935-01A0403EC54AQ58819436-7F6D6074-F8A2-45CF-9981-C8C20EBA5D6E
P2860
Dual-chamber pacing for hypertrophic cardiomyopathy: a randomized, double-blind, crossover trial.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
Dual-chamber pacing for hypert ...... double-blind, crossover trial.
@en
Dual-chamber pacing for hypert ...... double-blind, crossover trial.
@nl
type
label
Dual-chamber pacing for hypert ...... double-blind, crossover trial.
@en
Dual-chamber pacing for hypert ...... double-blind, crossover trial.
@nl
prefLabel
Dual-chamber pacing for hypert ...... double-blind, crossover trial.
@en
Dual-chamber pacing for hypert ...... double-blind, crossover trial.
@nl
P2093
P1476
Dual-chamber pacing for hypert ...... double-blind, crossover trial.
@en
P2093
Allison TG
Ilstrup DM
Nishimura RA
P304
P356
10.1016/S0735-1097(96)00473-1
P407
P577
1997-02-01T00:00:00Z